Cyrus Abbasi, MD
Pain Medicine · Las Vegas, NVNPI 1184112526
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,827 of the $7,903 with a category attached, or 61.1%. 14 manufacturers reported payments, led by Boston Scientific at 41.5% of the total.
Across 106 payments — averaging $74.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$1K
- Abbott$876
- Curonix LLC$862
- Painteq LLC$846
- Nevro Corp.$166
- plus $658 from 8 others
What the payments were for
- Travel & lodging$2,48631%
- Food & beverage$4,82761%
- Education$5907%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 48 | $3,284 |
| Medtronic | 15 | $1,212 |
| Abbott | 7 | $876 |
| Curonix LLC | 15 | $862 |
| Painteq LLC | 6 | $846 |
| Nevro Corp. | 2 | $166 |
| Vertos Medical, Inc. | 5 | $156 |
| Si-bone, Inc. | 1 | $134 |
| SPR Therapeutics, Inc | 1 | $98 |
| Stryker | 1 | $95 |
| Protega Pharmaceutials Inc | 1 | $52 |
| Spinal Simplicity, LLC | 1 | $49 |
| Biowound Solutions, Inc. | 1 | $49 |
| Relievant Medsystems, Inc. | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,903 in reported general payments places this provider in the 75th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $8,260 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 133 | $4,466 |
| Lidocaine | 13 | $756 |
| Gabapentin | 72 | $641 |
| Oxycodone Hcl | 34 | $573 |
| Pregabalin | 25 | $508 |
| Tizanidine Hcl | 45 | $358 |
| Cyclobenzaprine Hcl | 26 | $248 |
| Methocarbamol | 19 | $189 |
| Tramadol Hcl | 21 | $154 |
| Baclofen | 11 | $103 |
| Ibuprofen | 15 | $101 |
| Naproxen | 11 | $86 |
| Meloxicam | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.